Filing Flows › Maxlinear (MXL) › R&D spending
Maxlinear (MXL) R&D spending by quarter
Maxlinear's R&D spending was $60.6M in Q3 2026 (third quarter 2026), +8% from Q2 2026. Over the last 7 quarters it ranged from $47.2M (Q2 2025) to $60.6M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $60.6M | +8% | +12% |
| Q2 2026 | $56.0M | +5% | +19% |
| Q1 2026 | $53.2M | +3% | -4% |
| Q4 2025 | $51.7M | -5% | — |
| Q3 2025 | $54.3M | +15% | — |
| Q2 2025 | $47.2M | -15% | — |
| Q1 2025 | $55.5M | — | — |
Q3 2026 at a glance
Maxlinear, Q3 2026: revenue $218M (+72% year over year), operating margin 13.9%, net earnings $28.9M, operating cash flow −$13.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Maxlinear's R&D spending?
Maxlinear's R&D spending was $60.6M in Q3 2026 (third quarter 2026), +8% from Q2 2026.
How has Maxlinear's R&D spending changed?
Over the last 7 quarters it ranged from $47.2M (Q2 2025) to $60.6M (Q3 2026).